The TREAT PTSD Act directs the Veterans Affairs Department and Department of Defense to provide stellate ganglion block (a nerve-blocking injection procedure) as a treatment option for veterans and active-duty military members diagnosed with post-traumatic stress disorder. The bill makes this therapy available to enrolled veterans and TRICARE-eligible service members who have been informed of the risks and benefits and choose to receive the procedure, which can be delivered through VA facilities or participating health care providers. Within 180 days of enactment, the VA and Defense Department must update their joint clinical practice guidelines for PTSD management to reflect stellate ganglion block as an available therapy option and provide information on when it is clinically appropriate or inappropriate to use. The legislation does not specify dedicated funding amounts, but the provisions become effective 180 days after the bill is signed into law.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.